Tyler Merkeley MS, MBA is the interim Director of the Division of Research, Innovation, and Ventures (DRIVe) responsible for Transforming Health Security at the Biomedical Advanced Research and Development Authority’s (BARDA) within U.S. Department of Health and Human Services (HHS).
Tyler joined BARDA in 2009 as a Health Scientist to accelerate the advanced research and development, procurement, stockpile and sustainment of medical countermeasures (MCM) against biological, chemical, radiological, and nuclear (CBRN) agents under Project BioShield. Tyler’s expertise is in building and then leading novel public private partnerships in national security. During his tenure at BARDA he has led the smallpox antiviral procurement, co-founded HHS’s Combating Antibiotic Resistant Bacteria (CARB) Accelerator [CARB-X] initiative, managed BARDA’s 1st agreement using Other Transaction Authority (OTA), served as the Acting Chief of Staff for BARDA and most recently supported the design and launch of BARDA’s newest Division DRIVe. www.drive.hhs.gov